SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001140361-20-000641
Filing Date
2020-01-10
Accepted
2020-01-10 17:00:36
Documents
14
Period of Report
2020-01-09
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K form8k.htm   iXBRL 8-K 30402
2 EXHIBIT 10.1 ex10_1.htm EX-10.1 82971
6 image0.jpg GRAPHIC 86248
  Complete submission text file 0001140361-20-000641.txt   390988

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ions-20200109.xsd EX-101.SCH 4198
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ions-20200109_lab.xml EX-101.LAB 23692
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ions-20200109_pre.xml EX-101.PRE 16832
15 EXTRACTED XBRL INSTANCE DOCUMENT form8k_htm.xml XML 4062
Mailing Address 2855 GAZELLE COURT CARLSBAD CA 92010
Business Address 2855 GAZELLE COURT CARLSBAD CA 92010 7609319200
IONIS PHARMACEUTICALS INC (Filer) CIK: 0000874015 (see all company filings)

IRS No.: 330336973 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-19125 | Film No.: 20521829
SIC: 2834 Pharmaceutical Preparations